Its proposed mechanisms include enhanced insulin sensitivity, reduced circulating insulin and IGF-1 levels, and activation of the AMPK–mTOR signaling pathway, collectively suppressing oncogenic signaling and tumor proliferation. The gene discussed is IGF1; the disease is neoplasm.